Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized,

Grace Ndeezi1, Thorkild Tylleskär, Christopher M Ndugwa

  • 1Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda. gracendeezi@yahoo.com

Insights

Multiple micronutrient supplementation did not significantly reduce mortality in HIV-infected children in Uganda. The study found no significant differences in survival, growth, or CD4 counts between groups receiving high-dose or standard-dose multivitamins.

Area of Science:

  • Pediatric Infectious Diseases
  • Nutritional Science
  • Public Health in Low-Income Countries

Background:

  • Micronutrient deficiencies are a major threat to the survival of children with HIV in resource-limited settings.
  • This study investigated the impact of multiple micronutrient supplementation on mortality rates in HIV-infected children in Uganda.

Purpose of the Study:

  • To assess the effect of enhanced multiple micronutrient supplementation on the mortality of HIV-infected children.
  • To evaluate the impact of supplementation on growth and CD4 cell counts.

Main Methods:

  • A randomized controlled trial involving 847 children (aged 1-5 years) attending HIV clinics in Uganda.
  • Children received either twice the recommended dietary allowance of 14 micronutrients or the standard recommended dietary allowance of 6 multivitamins for six months.
  • Mortality was analyzed at 12 months using Kaplan-Meier curves and log-rank tests.

Main Results:

  • Mortality at 12 months was 5.9% in the intervention arm and 6.7% in the standard care arm (Risk Ratio 0.9; 95% CI 0.5-1.5).
  • No significant differences were observed in survival (p=0.64), mean weight-for-height, or mean CD4 cell counts between the groups.
  • Children on antiretroviral therapy (ART) had lower mortality (2.4%) compared to those not on ART (6.7%).

Conclusions:

  • Supplementation with twice the recommended dietary allowance of 14 micronutrients was well-tolerated but did not significantly impact mortality, growth, or CD4 counts in HIV-infected children.
  • Future studies should consider supplement composition, dosage, and adequate statistical power to detect differences.
Abstract

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
What is an Experiment?01:12

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...